Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Panacea Biotec LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:531349NSE Symbol: PANACEABIOP/E(TTM):0
ISIN Demat:INE922B01023Div & Yield %:0EPS(TTM):0
Book Value(Rs):47.6165751Market Cap ( Cr.):2182.36Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 309.86359.60257.07235.50343.56158.09
Excise Duty0.000.000.000.000.000.00
Net Sales309.86359.60257.07235.50343.56158.09
Other Income 16.6224.9134.4412.5720.7530.88
Stock Adjustments 23.06-17.79-31.1560.95-14.2428.18
Total Income349.54366.72260.36309.02350.07217.15
EXPENDITURE :      
Raw Materials 125.76123.90131.91173.04162.0286.71
Power & Fuel Cost28.4625.3322.4326.5120.7817.58
Employee Cost 97.0286.5371.0372.5059.4746.64
Other Manufacturing Expenses 43.0448.2036.3140.7645.7519.05
Selling and Administration Expenses 34.4129.9923.4145.8230.8721.56
Miscellaneous Expenses 11.1513.713.4510.519.97129.41
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure339.84327.65288.54369.13328.85320.94
Operating Profit9.6939.07-28.20-60.1121.21-103.80
Interest 15.4613.7810.067.047.525.27
Gross Profit-5.7725.29-38.26-67.1513.69-109.07
Depreciation20.2921.0924.5026.4326.5726.91
Profit Before Tax-26.064.20-62.76-93.58-12.88-135.98
Tax0.000.640.000.002.2739.88
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-10.830.0224.790.00-0.71-22.78
Reported Net Profit-15.233.55-87.54-93.58-14.44-153.07
Extraordinary Items 0.060.055.300.013.26-31.37
Adjusted Net Profit-15.293.50-92.84-93.59-17.70-121.70
Adjst. below Net Profit 0.05-0.06-1.900.501.38-3.03
P & L Balance brought forward-173.91-177.40-87.965.1218.18174.27
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down-189.08-173.91-177.40-87.965.1218.18
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr-2.490.58-14.29-15.28-2.36-24.99
Earnings Per Share(Adj)-Unit Curr-2.490.58-14.29-15.28-2.36-22.93
Book Value-Unit Curr47.7250.2049.6364.2479.43136.97